2020 annual financial data
Fate Therapeutics, Inc. 2020 Operating margin
Fate Therapeutics, Inc. 2020 operating margin with verified reported values.
Direct answer
Operating margin was -407.47%.
Operating income was -128,085,000 USD and net income was -173,387,000 USD.
Operating cash flow was -39,229,000 USD.
Get free Fate Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 31,434,000 USD
- Operating income
- -128,085,000 USD
- Net income
- -173,387,000 USD
- Operating cash flow
- -39,229,000 USD